Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

590 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study.
Sousa-Pinto B, Louis R, Anto JM, Amaral R, Sá-Sousa A, Czarlewski W, Brussino L, Canonica GW, Chaves Loureiro C, Cruz AA, Gemicioglu B, Haahtela T, Kupczyk M, Kvedariene V, Larenas-Linnemann DE, Okamoto Y, Ollert M, Pfaar O, Pham-Thi N, Puggioni F, Regateiro FS, Romantowski J, Sastre J, Scichilone N, Taborda-Barata L, Ventura MT, Agache I, Bedbrook A, Becker S, Bergmann KC, Bosnic-Anticevich S, Bonini M, Boulet LP, Brusselle G, Buhl R, Cecchi L, Charpin D, de Blay F, Del Giacco S, Ivancevich JC, Jutel M, Klimek L, Kraxner H, Kuna P, Laune D, Makela M, Morais-Almeida M, Nadif R, Niedoszytko M, Papadopoulos NG, Papi A, Patella V, Pétré B, Rivero Yeverino D, Robalo Cordeiro C, Roche N, Rouadi PW, Samolinski B, Savouré M, Shamji MH, Sheikh A, Suppli Ulrik C, Usmani OS, Valiulis A, Yorgancioglu A, Zuberbier T, Fonseca JA, Costa EM, Bousquet J. Sousa-Pinto B, et al. Among authors: papi a. Pulmonology. 2023 Aug 3:S2531-0437(23)00130-7. doi: 10.1016/j.pulmoe.2023.07.004. Online ahead of print. Pulmonology. 2023. PMID: 37543524 Free article.
MASK-air® direct patient data support the ARIA-MeDALL hypothesis on allergic phenotypes.
Bousquet J, Sousa-Pinto B, Regateiro FS, Pereira AM, Brussino L, Kvedariene V, Larenas-Linnemann DE, Taborda-Barata L, Ventura MT, Vieira RJ, Fonseca JA, Zuberbier T, Anto JM; ARIA Group. Bousquet J, et al. Allergy. 2023 Oct;78(10):2790-2794. doi: 10.1111/all.15842. Epub 2023 Aug 11. Allergy. 2023. PMID: 37564010 No abstract available.
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Cole J, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Mannent LP, Patel N, Staudinger HW, Yancopoulos GD, Mortensen ER, Akinlade B, Maloney J, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM; BOREAS Investigators. Bhatt SP, et al. Among authors: papi a. N Engl J Med. 2023 Jul 20;389(3):205-214. doi: 10.1056/NEJMoa2303951. Epub 2023 May 21. N Engl J Med. 2023. PMID: 37272521 Clinical Trial.
The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper.
Agache I, Adcock IM, Akdis CA, Akdis M, Bentabol-Ramos G, van den Berge M, Boccabella C, Canonica WG, Caruso C, Couto M, Davila I, Drummond D, Fonseca J, Gherasim A, Del Giacco S, Jackson DJ, Jutel M, Licari A, Loukides S, Moreira A, Mukherjee M, Ojanguren I, Palomares O, Papi A, Perez de Llano L, Price OJ, Rukhazde M, Shamji MH, Shaw D, Sanchez-Garcia S, Testera-Montes A, Torres MJ, Eguiluz-Gracia I. Agache I, et al. Among authors: papi a. Allergy. 2024 Dec 16. doi: 10.1111/all.16436. Online ahead of print. Allergy. 2024. PMID: 39676750
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial.
Singh D, Brightling CE, Rabe KF, Han MK, Christenson SA, Drummond MB, Papi A, Pavord ID, Molfino NA, Almqvist G, Kotalik A, Hellqvist Å, Gołąbek M, Sindhwani NS, Ponnarambil SS; COURSE study investigators. Singh D, et al. Among authors: papi a. Lancet Respir Med. 2025 Jan;13(1):47-58. doi: 10.1016/S2213-2600(24)00324-2. Epub 2024 Dec 6. Lancet Respir Med. 2025. PMID: 39653044 Clinical Trial.
GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry for the diagnosis of COPD.
Singh D, Stockley R, Anzueto A, Agusti A, Bourbeau J, Celli BR, Criner GJ, Han MK, Martinez FJ, Montes de Oca M, Ozoh OB, Papi A, Pavord I, Roche N, Salvi S, Sin DD, Troosters T, Wedzicha J, Zheng J, Volgelmeier C, Halpin D. Singh D, et al. Among authors: papi a. Eur Respir J. 2024 Dec 5:2401603. doi: 10.1183/13993003.01603-2024. Online ahead of print. Eur Respir J. 2024. PMID: 39638416
Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS).
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Dakin P, Maloney J, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM. Bhatt SP, et al. Among authors: papi a. Respir Med. 2025 Jan;236:107846. doi: 10.1016/j.rmed.2024.107846. Epub 2024 Oct 30. Respir Med. 2025. PMID: 39481660 Free article. Clinical Trial.
Call to Action: How Can We Promote the Development of New Pharmacologic Treatments in Chronic Obstructive Pulmonary Disease?
Belz DC, Putcha N, Alupo P, Siddharthan T, Baugh A, Hopkinson N, Castaldi P, Papi A, Mannino D, Miravitlles M, Han M, Fabbri LM, Montes de Oca M, Krishnan JA, Singh D, Martinez FJ, Hansel NN, Calverley P. Belz DC, et al. Among authors: papi a. Am J Respir Crit Care Med. 2024 Dec 1;210(11):1300-1307. doi: 10.1164/rccm.202311-2180PP. Am J Respir Crit Care Med. 2024. PMID: 39405496 No abstract available.
590 results